For the purification of recombinant Pam: The pellet of 1 liter of E. coli cells producing Pam was resuspended in 10 ml of buffer A (20 mM HEPES pH 7.5, 50 mM NaCl) and lysed by sonication. The buy ICG-001 insoluble fraction was pelleted by centrifugation at 4°C, 16 000× g, 20 min and the resulting

supernatant was diluted to 20 ml with buffer A. This supernatant was loaded as 5 ml fractions onto a 5 ml Hitrap QFF anion exchange chromatography column (GE Healthcare, UK) equilibrated with: 3 × column volumes (cv) buffer A, 3 × cv buffer B (20 mM HEPES pH 7.5, 1 M NaCl) and 3 × cv buffer A. Chromatography was performed on an ÄKTA purifier (GE Healthcare, UK). The column was run at 0.8 ml min-1 with a 15 ml wash after loading and a 5 × cv gradient from 5% to 100% buffer B to elute the protein. 1 ml fractions were collected and 10 μl samples were loaded for SDS-polyacrylamide gel electrophoresis. The Hitrap QFF step was followed by further anion exchange using a 1 ml MonoQ column (GE Healthcare, UK). Fractions containing Pam were diluted fourfold with buffer A and 4 ml were loaded after equilibration of the column. Pam was eluted with a gradient of 5%-25% buffer B over 8 cv, Proteasome inhibitor and fractions containing Pam were identified by SDS-PAGE. The estimated purity of Pam was 95%. RG-7388 clinical trial Extracellular-polysaccharide (EPS) crude extraction

Cells grown on LB agar were harvested with a minimal volume of 0.9% NaCl solution Adenosine triphosphate and EPS was detached by mixing for 15-20 s in a blender. Cells were pelleted and discarded, and 3 volumes of chilled acetone were added to the EPS-containing supernatant (previously concentrated to 30-40 ml by freeze-drying). The mixture was kept at -20°C overnight, centrifuged at 3 000 × g for 20 min and the pellet was dried and resuspended in a small volume (10-20 ml H2O). This sample was ultra-centrifuged at 100 000 × g for 4 h to precipitate the lipopolysaccharide fraction. The supernatant was removed and dialyzed overnight at 4°CC. Samples were frozen at -80°C for 4-6 h, and freeze-dried to concentrate. EPS suspensions (2 mg/ml) from TT01rif and TT01pam were analysed by SDS-PAGE and Pam was

detected by Western blot. A suspension of TT01rif EPS (5 mg/ml) was incubated with 1.6% SDS or salt (0.5 M KCl) or vortex for 4 mins before performing electrophoresis on native gel and Western blot. Virulence, toxicity and symbiosis assays For calculation of the LT50, or time taken for half of the initial population to die, approx 100 cells from overnight cultures of either TT01rif or TT01pam were injected per insect and 100 G. mellonella larvae were used per treatment. LT50 is the calculated time after injection at which 50% of the larval population was dead; differences in LT50 times represent different rates of killing. Scoring of insect death was carried out every 2 h between 44-52 h and 59-68 h post-injection.